1. Luo, Jingyi, Liu, Xin, Zhang, Yifei, Cheng, Bo, Yang, Sisi. 2023. Coexpression network analysis identified MT3 as a hub gene that promotes the chemoresistance of oral cancer by regulating the expression of YAP1. In BMC oral health, 23, 954. doi:10.1186/s12903-023-03600-z. https://pubmed.ncbi.nlm.nih.gov/38041044/
2. Li, Qi, Liu, Hengchen, Jin, Yun, Zhang, Xiaoxiao, Li, Jiangtao. 2023. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes. In Computers in biology and medicine, 165, 107370. doi:10.1016/j.compbiomed.2023.107370. https://pubmed.ncbi.nlm.nih.gov/37643511/
3. Tao, Yan-Fang, Xu, Li-Xiao, Lu, Jun, Feng, Xing, Pan, Jian. 2014. Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation. In Journal of translational medicine, 12, 182. doi:10.1186/1479-5876-12-182. https://pubmed.ncbi.nlm.nih.gov/24962166/
4. Mo, Shenzheng, Kim, Min Kyung, Jang, Ji Sun, Jung, Suhan, Kim, Hong-Hee. 2024. Unique expression and critical role of metallothionein 3 in the control of osteoclastogenesis and osteoporosis. In Experimental & molecular medicine, 56, 1791-1806. doi:10.1038/s12276-024-01290-3. https://pubmed.ncbi.nlm.nih.gov/39085359/